The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2,2-Dimethyl-6-morpholino-1-oxo-2,3-dihydro-1H-inden-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide ID: ALA4557715
PubChem CID: 129284027
Max Phase: Preclinical
Molecular Formula: C22H23N5O3
Molecular Weight: 405.46
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC1(C)Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O
Standard InChI: InChI=1S/C22H23N5O3/c1-22(2)12-14-10-17(18(11-15(14)19(22)28)26-6-8-30-9-7-26)25-21(29)16-13-24-27-5-3-4-23-20(16)27/h3-5,10-11,13H,6-9,12H2,1-2H3,(H,25,29)
Standard InChI Key: GZDUDIFYOWVYPG-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 34 0 0 0 0 0 0 0 0999 V2000
15.3739 -4.0034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0838 -3.5989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3786 -3.1864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0564 -4.4229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7660 -4.0135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7632 -3.1908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0546 -2.7856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3483 -4.0140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3495 -3.1929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5690 -2.9380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5670 -4.2665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4721 -4.4202 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.4714 -5.2383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1757 -5.6457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8851 -5.2395 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.8858 -4.4214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1770 -4.0094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4693 -2.7796 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.4663 -1.9624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1724 -1.5511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7570 -1.5565 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.0504 -0.5646 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.2518 -0.7377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4617 -1.2709 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.9150 -1.8782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1680 -2.6533 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.9673 -2.8221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5132 -2.2098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2573 -1.4371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3132 -5.0432 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
8 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 9 1 0
8 9 2 0
9 10 1 0
10 2 1 0
2 11 1 0
11 8 1 0
12 13 1 0
12 17 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
5 12 1 0
6 18 1 0
18 19 1 0
19 20 1 0
19 21 2 0
20 25 2 0
24 22 1 0
22 23 2 0
23 20 1 0
24 25 1 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
11 30 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 405.46Molecular Weight (Monoisotopic): 405.1801AlogP: 2.58#Rotatable Bonds: 3Polar Surface Area: 88.83Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.49CX Basic pKa: 0.43CX LogP: 2.60CX LogD: 2.60Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.72Np Likeness Score: -1.47
References 1. Rajapaksa NS, Gobbi A, Drobnick J, Do S, Kolesnikov A, Liang J, Chen Y, Sujatha-Bhaskar S, Huang Z, Brightbill H, Francis R, Yu C, Choo EF, DeMent K, Ran Y, An L, Emson C, Maher J, Wai J, McKenzie BS, Lupardus PJ, Zarrin AA, Kiefer JR, Bryan MC.. (2020) Discovery of Potent Benzolactam IRAK4 Inhibitors with Robust in Vivo Activity., 11 (3): [PMID:32184965 ] [10.1021/acsmedchemlett.9b00380 ]